Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
https://doi.org/10.21055/0370-1069-2015-3-73-76
Abstract
About the Authors
A. A. LopatinRussian Federation
E. V. Naidenova
Russian Federation
V. A. Safronov
Russian Federation
A. S. Razdorsky
Russian Federation
D. V. Utkin
Russian Federation
Zh. A. Kas’Yan
Russian Federation
A. A. Kritsky
Russian Federation
V. A. Ternovoy
Russian Federation
A. E. Nesterov
Russian Federation
A. A. Sergeev
Russian Federation
A. L. Sylla
Russian Federation
V. . Kanomou
Russian Federation
M. Y. Boiro
Russian Federation
Yu. V. Demina
Russian Federation
V. Yu. Khoroshilov
Russian Federation
A. Yu. Popova
Russian Federation
V. V. Kutyrev
Russian Federation
References
1. [Ebola virus disease]. WHO Information Bulletin No 103. [cited 17 Apr 2015]. Available from: http://www.who.int/mediacentre/factsheets/fs103/ru.
2. Popova A.Yu., Safronov V.A., Magasuba N.F., Utkin D.V., Odinokov G.N., P’yankov O.V., Sergeev A.S., Bodnev, S.A. Kabanov A.S., Kuklev V.E., Lopatin A.A., Razdorsky A.S., Nikiforov K.A., Shcherbakova S.A., Ternovoy V.A., Agafonov A.P., Mikheev V.N., Kutyrev V.V. [Management and performance of diagnostic investigations on the platform of the specialized anti-epidemic team mobile complex during EVD epidemics in 2014 in the Republic of Guinea]. Probl. Osobo Opasn. Infek. 2014; 4:5–8.
3. Clinical Management of Patients with Viral Hemorrhagic Fever: A Pocket Guide for the Front-line Health Worker. Geneva: World Health Organization; March 2014. 61 p.
4. Bausch D.G., Towner J.S., Dowell S.F., Kaducu F., Lukwiya M., Sanchez A. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J. Infect. Dis. 2007; 196(Suppl 2):S142–7.
5. Moreau M., Spencer C., Gozalbes J.G., Colebunders R., Lefevre A., Gryseels S., Borremans B., Gunther S., Becker D., Bore J.A., Koundouno F.R., Di Caro A., Wölfel R., Decroo T., Van Herp M., Peetermans L., Camara A.M. Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro Surveill. 2015; 20(3):pii 21017.
6. O’Dempsey T., Khan S.H., Bausch D.G. Rethinking the Discharge Policy for Ebola Convalescents in an Accelerating Epidemic. Am. J. Trop. Med. Hyg. 2015; 92(2):238–9.
7. Rowe A.K., Bertolli J., Khan A.S., Mukunu R., Muyembe-Tamfum J.J., Bressler D., Williams A.J., Peters C.J., Rodriguez L., Feldmann H., Nichol S.T., Rollin P.E., Ksiazek T.G. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J. Infect. Dis. 1999; 179(Suppl l):S28–35.
8. Strecker T., Palyi B., Ellerbrok H., Jonckheere S., de Clerck H., Bore J.A., Gabriel M., Stoecker K., Eickmann M, van Herp M., Formenty P., Di Caro A., Becker S. Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency. Clin. Infect. Dis. 2015; 61(5):669–75. DOI: 10.1093/cid/civ397.
Review
For citations:
Lopatin A.A., Naidenova E.V., Safronov V.A., Razdorsky A.S., Utkin D.V., Kas’Yan Zh.A., Kritsky A.A., Ternovoy V.A., Nesterov A.E., Sergeev A.A., Sylla A.L., Kanomou V., Boiro M.Y., Demina Yu.V., Khoroshilov V.Yu., Popova A.Yu., Kutyrev V.V. Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence. Problems of Particularly Dangerous Infections. 2015;(3):73-76. (In Russ.) https://doi.org/10.21055/0370-1069-2015-3-73-76